A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors
NCT04476641
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
686
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Kidney Cancer
Nasopharyngeal Cancer
Lung Cancer
Colorectal Cancer
Breast Cancer
Interventions
OTHER:
CELL
Sponsor
Sun Yat-sen University